P/B
0,3
BGM
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
$118.6M
Market Cap • 10/5/2026
2019
(7 years)
Founded
2021
(5 years ago)
IPO
NASDAQ
Listing Exchange
China
Country
Valuation
P/S
2,5
P/EBITDA
—
P/OCF
37,4
P/FCF
81,2
P/E
—
BVPS
31,4
EPS
—
Market Cap
Market Cap
118,6M
EV
109,8M
EV/Revenue
2,3
EV/EBITDA
-11,9
EV/EBIT
-9,8
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
0%
Total Yield
0%
Payout
0%
Retained Earnings
-14,4M
Profitability
Gross Margin
16,9%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
0%
Capex/Revenue
3,6%
Capex/D&A
86,7%
Capex/OCF
54%
SBC/OCF
193,7%
% PPE
3,5%
% Goodwill
82,5%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
-1,7%
CAGR OCF 5Y
-19,7%
Leverage
N.D./EBITDA
1,1
Debt/Equity
0%
Current Ratio
1,3
Quick Ratio
0,5
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!